RespireRx Pharmaceuticals Inc.
RSPI
$0.0021
$0.0011110.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.40K | 7.30K | 100.00 | 100.00 | 100.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 47.30K | 77.20K | 95.70K | 22.70K | 50.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 55.00K | 56.80K | -- | -- | -- |
| Total Current Assets | 108.70K | 141.30K | 95.90K | 22.80K | 50.60K |
|
|
|||||
| Total Current Assets | 108.70K | 141.30K | 95.90K | 22.80K | 50.60K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 108.70K | 141.30K | 95.90K | 22.80K | 50.60K |
|
|
|||||
| Total Accounts Payable | 3.65M | 2.59M | 2.52M | 4.77M | 5.43M |
| Total Accrued Expenses | 2.70M | 3.50M | 3.53M | 3.30M | 3.13M |
| Short-term Debt | 2.78M | 2.87M | 2.85M | 2.71M | 2.56M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.93M | 3.25M | 3.38M | 950.60K | 321.00K |
| Total Other Current Liabilities | 2.93M | 3.25M | 3.38M | 950.60K | 321.00K |
| Total Current Liabilities | 12.06M | 12.21M | 12.29M | 11.73M | 11.44M |
|
|
|||||
| Total Current Liabilities | 12.06M | 12.21M | 12.29M | 11.73M | 11.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.78M | 2.87M | 2.85M | 2.71M | 2.56M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 344.00K | 74.00K | 119.00K | 174.00K | 204.00K |
| Total Liabilities | 12.41M | 12.28M | 12.41M | 11.90M | 11.64M |
|
|
|||||
| Common Stock & APIC | 164.46M | 164.35M | 164.16M | 164.16M | 164.16M |
| Retained Earnings | -177.56M | -177.17M | -176.49M | -176.06M | -175.77M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -13.11M | -12.81M | -12.33M | -11.90M | -11.61M |
|
|
|||||
| Preferred Stock Redeemable | 789.40K | 650.80K | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 21.70K | 21.70K | 21.70K | 21.70K | 21.70K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 811.10K | 672.50K | 21.70K | 21.70K | 21.70K |
|
|
|||||
| Total Common Equity | -13.11M | -12.81M | -12.33M | -11.90M | -11.61M |
| Total Preferred Equity | 811.10K | 672.50K | 21.70K | 21.70K | 21.70K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.30M | -12.14M | -12.31M | -11.88M | -11.59M |
|
|
|||||